- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04844671
Patients' Expectations About Effects of Robotic Surgery for Cancer
April 26, 2022 updated by: First Affiliated Hospital Xi'an Jiaotong University
Robotic surgery for common surgical procedures is on the rise despite limited evidence to support its clinical benefit.
We intend to to map and characterize the prevalence of the patients'expectation that robotic surgery might be superior to open or laparoscopic procedures and to identify the sociodemographic, clinical and organisational factors associated with this expectation.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
With the progress of modern medicine, minimally invasive surgical technology has become the main theme in the field of contemporary surgery.
As a rising star, the Da Vinci robotic surgery system provides surgeons with a more comprehensive surgical vision, more flexible instrument control, finer anatomy, and more natural comfort compared to open surgery and laparoscopic surgery.
However, due to the lack of long-term theoretical basis, the evidence to support its clinical benefits is limited, and its application is limited by related postoperative complications and high operation-related costs.
At present, the number of Da Vinci robotic surgery is steadily increasing around the world, but what are the expectations of patients that robotic surgery may be better than open or laparoscopic surgery?
It is also unclear what reasons are related to this established expectation.
Therefore, we intend to map and characterize the prevalence of the patients' expectation that robotic surgery might be superior to open or laparoscopic procedures and to identify the sociodemographic, clinical and organisational factors associated with this expectation.
Study Type
Observational
Enrollment (Anticipated)
3000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yong Zhang, DR
- Phone Number: 008685324610
- Email: yongzhang761@mail.xjtu.edu.cn
Study Contact Backup
- Name: Rui Jia
- Phone Number: 008613576945538
- Email: jrdoc123@163.com
Study Locations
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 70061
- Recruiting
- The First Affiliated Hospital of Xi'an Jiaotong University
-
Contact:
- Rui Jia
- Phone Number: 008613576945538
- Email: jrdoc123@163.com
-
Contact:
- YONG ZHNAG, DR
- Phone Number: 008613709110938
- Email: yongzhang761@mail.xjtu.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All patients who have undergone Da Vinci robotic surgery in the first affiliated hospital of Xi'an Jiaotong University in the past five years
Description
Inclusion Criteria:
- Clinical diagnosis of Cancer
- Have undergone tumor resection with Da Vinci Robotic Surgery System
- Volunteer to participate in the study
Exclusion Criteria:
- Patients with mental illness
- Cognitive dysfunction
- Cannot complete the questionnaire independently
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Other
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Factors Associated With Patients' Decisions Factors Associated With Patients'Decisions to Choose Robotic Surgery
Time Frame: 2021.4-2022.4
|
Factors Associated With Patients'Trends in the Adoption of Robotic Surgery for Common Surgical Procedures。According to the relevant regulations of the hospital inpatient satisfaction survey, we have developed a satisfaction rating scale, the evaluation is divided into five grades: "very satisfied" = 5, "relatively satisfied" = 4, "general" = 3, "not very satisfied" = 2, "very dissatisfied" = 1, the total score is 1-5.
|
2021.4-2022.4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Social demographic characteristics
Time Frame: 2021.4-2022.4
|
Age, Sex, Education, Occupation
|
2021.4-2022.4
|
Economic status
Time Frame: 2021.4-2022.4
|
The ability to pay for medical expenses and the type of medical insurance.Based on the types of medical insurance in China, our survey design is divided into four categories: 1.
China new rural cooperative medical system; 2. The medical insurance for urban residents; 3. The medical insurance for urban workers; 4. Commercial insurance.
According to China's national income level, our survey design is divided into three stages: personal annual income below 50,000 RMB, 50,000-100,000 RMB, and more than 100,000 RMB.
|
2021.4-2022.4
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Yong Zhang, First Affiliated Hospital Xi'an Jiaotong University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 20, 2021
Primary Completion (Anticipated)
June 1, 2022
Study Completion (Anticipated)
June 30, 2022
Study Registration Dates
First Submitted
April 4, 2021
First Submitted That Met QC Criteria
April 13, 2021
First Posted (Actual)
April 14, 2021
Study Record Updates
Last Update Posted (Actual)
April 28, 2022
Last Update Submitted That Met QC Criteria
April 26, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- XJTU1AF2021LSK-068
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
Study Protocol
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
Clinical Trials on da Vinci Surgical Systems
-
Deborah Farr, MDRecruitingBreast Cancer | High Risk of Breast CancerUnited States
-
Mayo ClinicRecruitingHead and Neck Cancer | Oropharyngeal NeoplasmsUnited States
-
Chang Gung Memorial HospitalActive, not recruitingThymoma | Myasthenia Gravis | Robotic Surgical ProcedureTaiwan
-
Wake Forest University Health SciencesCompletedHead and Neck NeoplasmsUnited States
-
Intuitive SurgicalCompleted
-
Ruijin HospitalRecruiting
-
IHU StrasbourgCompletedCholelithiasis | Gallbladder PolypsFrance
-
National Cancer Center, KoreaUnknown
-
Intuitive SurgicalCompletedBariatric Surgery CandidateUnited States
-
University Health Network, TorontoCompletedHead and Neck Squamous Cell CarcinomaCanada